Low molecular weight heparin in treating patients with lung cancer received chemotherapy: A meta-analysis
Conclusion: LMWH improves the 1- and 2-year OS rates of the patients with lung cancer received chemotherapy and reduces the incidence of VTE, not increase the incidence of major bleeding events and thrombocytopenia. These show that there is a certain effect of LMWH, and the security is good.
Source: Journal of Cancer Research and Therapeutics - Category: Cancer & Oncology Authors: Zi-Li Liu Qian Wang Ming Wang Bin Wang Li-Nian Huang Source Type: research
More News: Bleeding | Cancer | Cancer & Oncology | Chemotherapy | China Health | Databases & Libraries | Lung Cancer | Study | Thrombocytopenia | Thrombosis